In the BioHarmony Drug Report Database

"Preview" Icon

Mexiletine

Mexitil, Namuscla (mexiletine) is a small molecule pharmaceutical. Mexiletine was first approved as Mexitil on 1985-12-30. It is used to treat cardiac arrhythmias, diabetic neuropathies, ventricular fibrillation, and ventricular premature complexes in the USA. It has been approved in Europe to treat myotonic disorders. The pharmaceutical is active against sodium channel protein type 4 subunit alpha.

 

Trade Name

 

Namuscla
 

Common Name

 

mexiletine
 

ChEMBL ID

 

CHEMBL558
 

Indication

 

cardiac arrhythmias, diabetic neuropathies, myotonic disorders, ventricular fibrillation, ventricular premature complexes
 

Drug Class

 

Image (chem structure or protein)

Mexiletine structure rendering